drugset / Trial / NCT05386368

RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients

NCT05386368 ↗

RandomizedSingle-groupTriple-blindTreatment

Summary

To determine whether following Carbon dioxide (CO2) laser treatment, application of autologous cell suspension obtained via enzymatic and mechanical preparation will reduce negative side effects from CO2 laser and decrease the time of healing following treatment.

Timeline

Start
2023-03-22
Primary completion
2023-07-07
Completion
2024-05-06

Outcome

Outcome not reported

Stopped (Enrollment): “Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. PI decided to terminate due to slow enrollment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject ReCell Cell therapy — —

Indications

No indication recorded.